Darryl Sampey

500 total citations
11 papers, 155 citations indexed

About

Darryl Sampey is a scholar working on Molecular Biology, Genetics and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Darryl Sampey has authored 11 papers receiving a total of 155 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Genetics and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Darryl Sampey's work include Bacillus and Francisella bacterial research (3 papers), Virus-based gene therapy research (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). Darryl Sampey is often cited by papers focused on Bacillus and Francisella bacterial research (3 papers), Virus-based gene therapy research (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). Darryl Sampey collaborates with scholars based in United States. Darryl Sampey's co-authors include Jay W. Hooper, Eric M. Mucker, Suzanne E. Wollen-Roberts, Priya Karmali, Jerel Vega, Steve Cai, Stephen Horrigan, Pascal Courville, Steven A. Kwilas and Rajesh Mukthavaram and has published in prestigious journals such as PLoS ONE, Scientific Reports and eLife.

In The Last Decade

Darryl Sampey

10 papers receiving 148 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Darryl Sampey United States	7	83	41	40	37	21	11	155
Maher Elsheikh United States	8	137 1.7×	41 1.0×	90 2.3×	105 2.8×	27 1.3×	11	280
Ekaterina V. Starostina Russia	8	159 1.9×	43 1.0×	61 1.5×	27 0.7×	68 3.2×	30	210
Kevin M. Tuffy United States	7	73 0.9×	89 2.2×	52 1.3×	23 0.6×	43 2.0×	12	181
Sofiya Fedosyuk Austria	9	72 0.9×	53 1.3×	49 1.2×	55 1.5×	32 1.5×	11	181
Katharine M. Jenike United States	6	66 0.8×	21 0.5×	64 1.6×	86 2.3×	40 1.9×	10	168
Misaki Matsuo Japan	9	74 0.9×	23 0.6×	37 0.9×	36 1.0×	92 4.4×	21	199
Cheng‐Feng Chiang United States	8	86 1.0×	58 1.4×	97 2.4×	10 0.3×	19 0.9×	14	240
Tammy C. T. Lan United States	5	238 2.9×	24 0.6×	62 1.6×	11 0.3×	21 1.0×	7	316
Ericka N. Pompa‐Mera Mexico	8	43 0.5×	27 0.7×	71 1.8×	17 0.5×	17 0.8×	18	161
Jyotsana J. Parmar India	8	220 2.7×	14 0.3×	28 0.7×	47 1.3×	17 0.8×	8	260

Countries citing papers authored by Darryl Sampey

Since Specialization

Citations

This map shows the geographic impact of Darryl Sampey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Darryl Sampey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Darryl Sampey more than expected).

Fields of papers citing papers by Darryl Sampey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Darryl Sampey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Darryl Sampey. The network helps show where Darryl Sampey may publish in the future.

Co-authorship network of co-authors of Darryl Sampey

This figure shows the co-authorship network connecting the top 25 collaborators of Darryl Sampey. A scholar is included among the top collaborators of Darryl Sampey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Darryl Sampey. Darryl Sampey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Hausfeld, Jeffrey N., et al.. (2023). Pharmacokinetic Profiles of a Proposed Biosimilar Ustekinumab (BFI‐751): Results From a Randomized Phase 1 Trial. Clinical Pharmacology in Drug Development. 12(10). 1001–1012. 3 indexed citations

Raleigh, Michael D., Nicola Beltraminelli, Mark LeSage, et al.. (2021). Attenuating nicotine’s effects with high affinity human anti-nicotine monoclonal antibodies. PLoS ONE. 16(7). e0254247–e0254247. 5 indexed citations

Mucker, Eric M., Priya Karmali, Jerel Vega, et al.. (2020). Lipid Nanoparticle Formulation Increases Efficiency of DNA-Vectored Vaccines/Immunoprophylaxis in Animals Including Transchromosomic Bovines. Scientific Reports. 10(1). 8764–8764. 35 indexed citations

Sampey, Darryl, et al.. (2018). Enhanced expression of a biosimilar monoclonal antibody with a novel NS0 platform. Biotechnology Progress. 34(2). 455–462. 4 indexed citations

Mucker, Eric M., et al.. (2018). Intranasal monkeypox marmoset model: Prophylactic antibody treatment provides benefit against severe monkeypox virus disease. PLoS neglected tropical diseases. 12(6). e0006581–e0006581. 41 indexed citations

Horrigan, Stephen, et al.. (2017). Replication Study: Melanoma genome sequencing reveals frequent PREX2 mutations. eLife. 6. 15 indexed citations

Sampey, Darryl, et al.. (2015). Registered report: Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells. eLife. 4. 11 indexed citations

Sampey, Darryl, Pascal Courville, Nicole Perfito, et al.. (2013). Study 44: Replication of Berger et al., 2012 (Nature). OSF Preprints (OSF Preprints). 1 indexed citations

Terrell, Jessica L., Yi Cheng, Hsuan‐Chen Wu, et al.. (2011). Integrated biofabrication for electro‐addressed in‐film bioprocessing. Biotechnology Journal. 7(3). 428–439. 9 indexed citations

10.

Branco, Luis M., Joseph N. Fair, Augustine Goba, et al.. (2008). Bacterial-based systems for expression and purification of recombinant Lassa virus proteins of immunological relevance. Virology Journal. 5(1). 74–74. 17 indexed citations

11.

Gwinn, William M., et al.. (2005). Scalable purification of Bacillus anthracis protective antigen from Escherichia coli. Protein Expression and Purification. 45(1). 30–36. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact